CV Sciences (CVSI) Receivables - Other (2013 - 2023)

CV Sciences has disclosed Receivables - Other across 9 years of filings, most recently posting $6.4 million for Q1 2023.

• Receivables - Other for Q1 2023 came in at $6.4 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2023 was $6.4 million (changed 0.0% YoY), and the FY2022 annual result was $6.4 million, up 2033.33% from the prior year.
• Receivables - Other came in at $6.4 million for Q1 2023 at CV Sciences, roughly flat from $6.4 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $6.4 million in Q3 2019 to a low of $300000.0 in Q4 2021.
• The 5-year median for Receivables - Other is $6.4 million (2019), against an average of $5.9 million.
• Across the five-year window, Receivables - Other slumped 95.16% in 2021 and soared 2033.33% in 2022, its largest moves.
• CV Sciences' Receivables - Other stood at $6.4 million in 2019, then retreated by 3.12% to $6.2 million in 2020, then plunged by 95.16% to $300000.0 in 2021, then jumped by 2033.33% to $6.4 million in 2022, then changed by 0.0% to $6.4 million in 2023.
• The last three Receivables - Other figures came in at $6.4 million (Q1 2023), $6.4 million (Q4 2022), and $6.4 million (Q3 2022), per Business Quant data.